SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-069064
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:12
Documents
14
Period of Report
2024-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416573d1_8k.htm   iXBRL 8-K 42788
  Complete submission text file 0001104659-24-069064.txt   259857

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20240605.xsd EX-101.SCH 3263
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20240605_def.xml EX-101.DEF 26192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20240605_lab.xml EX-101.LAB 35952
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20240605_pre.xml EX-101.PRE 24850
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416573d1_8k_htm.xml XML 4919
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 241025010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)